ParkinsonCanadaV1, PascalFrancis, Curation, bibRecord, 000A68

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Identifieur interne : 000A68 ( PascalFrancis/Curation ); précédent : 000A67; suivant : 000A69

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Auteurs : Evelyne Matteau [Canada] ; Nicolas Dupre [Canada] ; Mélanie Langlois [Canada] ; Pierre Provencher [Canada] ; Martine Simard [Canada]

Source :

Journal of geriatric psychiatry and neurology [ 0891-9887 ] ; 2012.

RBID : Pascal:12-0276402

Descripteurs français

Pascal (Inist)
- Démence, Validité, Echelle d'évaluation, Maladie de Parkinson, Dépistage, Criblage, Trouble cognitif, Gériatrie, Personne âgée, Déficit cognitif léger, Gérontologie, Neurologie.
Wicri :
- topic : Personne âgée, Gérontologie, Neurologie.

English descriptors

KwdEn :
- Cognitive disorder, Dementia, Elderly, Evaluation scale, Geriatrics, Gerontology, Medical screening, Neurology, Parkinson disease, Screening, Validity, mild cognitive impairment.

Abstract

The utility of the Mattis Dementia Rating Scale 2 (MDRS-2) in screening for dementia in Parkinson disease (PD) is well documented. However, little is known about its sensitivity to mild cognitive impairment in PD (PD-MCI). This study sought to document the validity of the MDRS-2 for diagnoses of PD-MCI and dementia in PD (PDD). Twenty-two healthy controls (HCs), 22 PD-MCI, and 16 PDD were compared on each MDRS-2 subscales and MDRS-2 total standard scores. Patients with PDD performed significantly worse than the other groups (all Ps < .05) on the MDRS-2 total and on all subscales, except attention. PD-MCI had significant lower scores than HCs on the MDRS-2 total and on initiation/perseveration and memory subscales. The optimal cutoff score for PD-MCI diagnosis was ≤ 140/144 and < 132/144 for PDD. These findings suggest that MDRS-2 is a useful tool to identify dementia but that there might be a ceiling effect in the MDRS-2 cutoff score to diagnose MCI in PD.

A01	`01`	`1`		`@0 0891-9887`
A03		`1`		`@0 J. geriatr. psychiatry neurol.`
A05				`@2 25`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia`
A11	`01`	`1`		`@1 MATTEAU (Evelyne)`
A11	`02`	`1`		`@1 DUPRE (Nicolas)`
A11	`03`	`1`		`@1 LANGLOIS (Mélanie)`
A11	`04`	`1`		`@1 PROVENCHER (Pierre)`
A11	`05`	`1`		`@1 SIMARD (Martine)`
A14	`01`			`@1 École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard @2 Quebec City, QC @3 CAN @Z 1 aut. @Z 5 aut.`
A14	`02`			`@1 Faculty of Medicine, Université Laval @2 Quebec, Quebec @3 CAN @Z 2 aut. @Z 3 aut.`
A14	`03`			`@1 Department of Neurological Sciences, CHA-Enfant-Jésus @2 Quebec City, QC @3 CAN @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A20				`@1 100-106`
A21				`@1 2012`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 21396 @5 354000500812570050`
A44				`@0 0000 @1 © 2012 INIST-CNRS. All rights reserved.`
A45				`@0 45 ref.`
A47	`01`	`1`		`@0 12-0276402`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of geriatric psychiatry and neurology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 The utility of the Mattis Dementia Rating Scale 2 (MDRS-2) in screening for dementia in Parkinson disease (PD) is well documented. However, little is known about its sensitivity to mild cognitive impairment in PD (PD-MCI). This study sought to document the validity of the MDRS-2 for diagnoses of PD-MCI and dementia in PD (PDD). Twenty-two healthy controls (HCs), 22 PD-MCI, and 16 PDD were compared on each MDRS-2 subscales and MDRS-2 total standard scores. Patients with PDD performed significantly worse than the other groups (all Ps < .05) on the MDRS-2 total and on all subscales, except attention. PD-MCI had significant lower scores than HCs on the MDRS-2 total and on initiation/perseveration and memory subscales. The optimal cutoff score for PD-MCI diagnosis was ≤ 140/144 and < 132/144 for PDD. These findings suggest that MDRS-2 is a useful tool to identify dementia but that there might be a ceiling effect in the MDRS-2 cutoff score to diagnose MCI in PD.
C02	`01`	`X`		`@0 002B18E`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002A25`
C03	`01`	`X`	`FRE`	`@0 Démence @5 01`
C03	`01`	`X`	`ENG`	`@0 Dementia @5 01`
C03	`01`	`X`	`SPA`	`@0 Demencia @5 01`
C03	`02`	`X`	`FRE`	`@0 Validité @5 02`
C03	`02`	`X`	`ENG`	`@0 Validity @5 02`
C03	`02`	`X`	`SPA`	`@0 Validez @5 02`
C03	`03`	`X`	`FRE`	`@0 Echelle d'évaluation @5 03`
C03	`03`	`X`	`ENG`	`@0 Evaluation scale @5 03`
C03	`03`	`X`	`SPA`	`@0 Escala evaluación @5 03`
C03	`04`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 04`
C03	`04`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 04`
C03	`04`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 04`
C03	`05`	`X`	`FRE`	`@0 Dépistage @5 05`
C03	`05`	`X`	`ENG`	`@0 Medical screening @5 05`
C03	`05`	`X`	`SPA`	`@0 Descubrimiento @5 05`
C03	`06`	`X`	`FRE`	`@0 Criblage @5 06`
C03	`06`	`X`	`ENG`	`@0 Screening @5 06`
C03	`06`	`X`	`SPA`	`@0 Cernido @5 06`
C03	`07`	`X`	`FRE`	`@0 Trouble cognitif @5 07`
C03	`07`	`X`	`ENG`	`@0 Cognitive disorder @5 07`
C03	`07`	`X`	`SPA`	`@0 Trastorno cognitivo @5 07`
C03	`08`	`X`	`FRE`	`@0 Gériatrie @5 08`
C03	`08`	`X`	`ENG`	`@0 Geriatrics @5 08`
C03	`08`	`X`	`SPA`	`@0 Geriatría @5 08`
C03	`09`	`X`	`FRE`	`@0 Personne âgée @5 09`
C03	`09`	`X`	`ENG`	`@0 Elderly @5 09`
C03	`09`	`X`	`SPA`	`@0 Anciano @5 09`
C03	`10`	`X`	`FRE`	`@0 Déficit cognitif léger @2 NM @5 10`
C03	`10`	`X`	`ENG`	`@0 mild cognitive impairment @2 NM @5 10`
C03	`10`	`X`	`SPA`	`@0 Disturbio cognitivo ligero @2 NM @5 10`
C03	`11`	`X`	`FRE`	`@0 Gérontologie @5 11`
C03	`11`	`X`	`ENG`	`@0 Gerontology @5 11`
C03	`11`	`X`	`SPA`	`@0 Gerontología @5 11`
C03	`12`	`X`	`FRE`	`@0 Neurologie @5 12`
C03	`12`	`X`	`ENG`	`@0 Neurology @5 12`
C03	`12`	`X`	`SPA`	`@0 Neurología @5 12`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Maladie dégénérative @5 37`
C07	`02`	`X`	`ENG`	`@0 Degenerative disease @5 37`
C07	`02`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 37`
C07	`03`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 38`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 38`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 39`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 39`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 39`
C07	`05`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`05`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`05`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`06`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 41`
C07	`06`	`X`	`ENG`	`@0 Nervous system diseases @5 41`
C07	`06`	`X`	`SPA`	`@0 Sistema nervioso patología @5 41`
N21				`@1 205`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000184
to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000256

Links to Exploration step

Pascal:12-0276402

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia</title>
<author><name sortKey="Matteau, Evelyne" sort="Matteau, Evelyne" uniqKey="Matteau E" first="Evelyne" last="Matteau">Evelyne Matteau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dupre, Nicolas" sort="Dupre, Nicolas" uniqKey="Dupre N" first="Nicolas" last="Dupre">Nicolas Dupre</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Langlois, Melanie" sort="Langlois, Melanie" uniqKey="Langlois M" first="Mélanie" last="Langlois">Mélanie Langlois</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Provencher, Pierre" sort="Provencher, Pierre" uniqKey="Provencher P" first="Pierre" last="Provencher">Pierre Provencher</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Simard, Martine" sort="Simard, Martine" uniqKey="Simard M" first="Martine" last="Simard">Martine Simard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0276402</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0276402 INIST</idno>
<idno type="RBID">Pascal:12-0276402</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000184</idno>
<idno type="stanalyst">FRANCIS 12-0276402 INIST</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000256</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000A68</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia</title>
<author><name sortKey="Matteau, Evelyne" sort="Matteau, Evelyne" uniqKey="Matteau E" first="Evelyne" last="Matteau">Evelyne Matteau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dupre, Nicolas" sort="Dupre, Nicolas" uniqKey="Dupre N" first="Nicolas" last="Dupre">Nicolas Dupre</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Langlois, Melanie" sort="Langlois, Melanie" uniqKey="Langlois M" first="Mélanie" last="Langlois">Mélanie Langlois</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Provencher, Pierre" sort="Provencher, Pierre" uniqKey="Provencher P" first="Pierre" last="Provencher">Pierre Provencher</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Simard, Martine" sort="Simard, Martine" uniqKey="Simard M" first="Martine" last="Simard">Martine Simard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of geriatric psychiatry and neurology</title>
<title level="j" type="abbreviated">J. geriatr. psychiatry neurol.</title>
<idno type="ISSN">0891-9887</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of geriatric psychiatry and neurology</title>
<title level="j" type="abbreviated">J. geriatr. psychiatry neurol.</title>
<idno type="ISSN">0891-9887</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cognitive disorder</term>
<term>Dementia</term>
<term>Elderly</term>
<term>Evaluation scale</term>
<term>Geriatrics</term>
<term>Gerontology</term>
<term>Medical screening</term>
<term>Neurology</term>
<term>Parkinson disease</term>
<term>Screening</term>
<term>Validity</term>
<term>mild cognitive impairment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Démence</term>
<term>Validité</term>
<term>Echelle d'évaluation</term>
<term>Maladie de Parkinson</term>
<term>Dépistage</term>
<term>Criblage</term>
<term>Trouble cognitif</term>
<term>Gériatrie</term>
<term>Personne âgée</term>
<term>Déficit cognitif léger</term>
<term>Gérontologie</term>
<term>Neurologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Personne âgée</term>
<term>Gérontologie</term>
<term>Neurologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The utility of the Mattis Dementia Rating Scale 2 (MDRS-2) in screening for dementia in Parkinson disease (PD) is well documented. However, little is known about its sensitivity to mild cognitive impairment in PD (PD-MCI). This study sought to document the validity of the MDRS-2 for diagnoses of PD-MCI and dementia in PD (PDD). Twenty-two healthy controls (HCs), 22 PD-MCI, and 16 PDD were compared on each MDRS-2 subscales and MDRS-2 total standard scores. Patients with PDD performed significantly worse than the other groups (all Ps < .05) on the MDRS-2 total and on all subscales, except attention. PD-MCI had significant lower scores than HCs on the MDRS-2 total and on initiation/perseveration and memory subscales. The optimal cutoff score for PD-MCI diagnosis was ≤ 140/144 and < 132/144 for PDD. These findings suggest that MDRS-2 is a useful tool to identify dementia but that there might be a ceiling effect in the MDRS-2 cutoff score to diagnose MCI in PD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0891-9887</s0>
</fA01>
<fA03 i2="1"><s0>J. geriatr. psychiatry neurol.</s0>
</fA03>
<fA05><s2>25</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MATTEAU (Evelyne)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DUPRE (Nicolas)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>LANGLOIS (Mélanie)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PROVENCHER (Pierre)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SIMARD (Martine)</s1>
</fA11>
<fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>100-106</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21396</s2>
<s5>354000500812570050</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>45 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0276402</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of geriatric psychiatry and neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The utility of the Mattis Dementia Rating Scale 2 (MDRS-2) in screening for dementia in Parkinson disease (PD) is well documented. However, little is known about its sensitivity to mild cognitive impairment in PD (PD-MCI). This study sought to document the validity of the MDRS-2 for diagnoses of PD-MCI and dementia in PD (PDD). Twenty-two healthy controls (HCs), 22 PD-MCI, and 16 PDD were compared on each MDRS-2 subscales and MDRS-2 total standard scores. Patients with PDD performed significantly worse than the other groups (all Ps < .05) on the MDRS-2 total and on all subscales, except attention. PD-MCI had significant lower scores than HCs on the MDRS-2 total and on initiation/perseveration and memory subscales. The optimal cutoff score for PD-MCI diagnosis was ≤ 140/144 and < 132/144 for PDD. These findings suggest that MDRS-2 is a useful tool to identify dementia but that there might be a ceiling effect in the MDRS-2 cutoff score to diagnose MCI in PD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B18E</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002A25</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Démence</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Dementia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Demencia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Validité</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Validity</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Validez</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Echelle d'évaluation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Evaluation scale</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Escala evaluación</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Dépistage</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Medical screening</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Descubrimiento</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Criblage</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Screening</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Cernido</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Trouble cognitif</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Cognitive disorder</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Trastorno cognitivo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Gériatrie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Geriatrics</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Geriatría</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Elderly</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Anciano</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Déficit cognitif léger</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>mild cognitive impairment</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Disturbio cognitivo ligero</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Gérontologie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Gerontology</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Gerontología</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Neurologie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Neurology</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Neurología</s0>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>205</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A68 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000A68 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:12-0276402
   |texte=   Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri